The Investment Team at BioStar Capital identifies and evaluates promising medical device technologies in cardiovascular and orthopaedic sectors, conducting in-depth market analysis and due diligence. With a focus on value-add investments, they leverage industry expertise to support portfolio companies in achieving growth and innovation, while strategically guiding them through the investment lifecycle.